amantadine has been researched along with Acute Autoimmune Neuropathy in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine was not superior to placebo." | 6.72 | Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial. ( Garssen, MP; Jacobs, BC; Merkies, IS; Schmitz, PI; van der Meché, FG; van Doorn, PA, 2006) |
| " The effects of amantadine from one randomised, double-blind, placebo-controlled, cross-over trial comparing amantadine with placebo for the treatment of fatigue in 80 people with Guillain-Barré syndrome (GBS) were uncertain for the proportion of people achieving a favourable outcome six weeks post-intervention (odds ratio (OR) 0." | 4.90 | Interventions for fatigue in peripheral neuropathy. ( Garssen, MP; Stockley, RC; van Doorn, PA; White, CM, 2014) |
| "The most common subtypes of GBS are acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN)." | 2.82 | Triggers of Guillain-Barré Syndrome: ( Finsterer, J, 2022) |
| "Amantadine was not superior to placebo." | 2.72 | Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial. ( Garssen, MP; Jacobs, BC; Merkies, IS; Schmitz, PI; van der Meché, FG; van Doorn, PA, 2006) |
| "The final subtype diagnosis was acute inflammatory demyelinating polyneuropathy (AIDP) in 16 patients (six met the criteria at the initial EDx study and 10 at follow-up) and acute motor axonal neuropathy (AMAN) in 10 patients (six initially)." | 1.91 | Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves. ( Chroni, E; Kefalopoulou, Z; Kintos, V; Veltsista, D, 2023) |
| "Several reports of RCF in acute inflammatory demyelinating polyneuropathy (AIDP) have suggested that it could be a manifestation of nodopathy." | 1.72 | Reversible conduction failure in acute inflammatory demyelinating polyneuropathy. ( Kim, S; Lee, EK; Sohn, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 6 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kalita, J | 1 |
| Misra, UK | 1 |
| Chaudhary, SK | 1 |
| Das, M | 1 |
| Mishra, A | 1 |
| Ranjan, A | 1 |
| Kumar, M | 1 |
| Kim, S | 2 |
| Lee, EK | 2 |
| Sohn, E | 2 |
| Finsterer, J | 3 |
| Veltsista, D | 3 |
| Kefalopoulou, Z | 3 |
| Kintos, V | 3 |
| Chroni, E | 3 |
| Jo, N | 1 |
| Agarwal, E | 1 |
| Bhagat, A | 1 |
| Srivastava, K | 1 |
| Thakore, B | 1 |
| Jagtap, S | 1 |
| Kalane, U | 1 |
| Rajadhyaksha, S | 1 |
| Gupta, J | 1 |
| Jauhari, P | 1 |
| White, CM | 1 |
| van Doorn, PA | 2 |
| Garssen, MP | 2 |
| Stockley, RC | 1 |
| Schmitz, PI | 1 |
| Merkies, IS | 1 |
| Jacobs, BC | 1 |
| van der Meché, FG | 1 |
3 reviews available for amantadine and Acute Autoimmune Neuropathy
| Article | Year |
|---|---|
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
Triggers of Guillain-Barré Syndrome:
Topics: Amantadine; Autoantibodies; Axons; Campylobacter jejuni; Guillain-Barre Syndrome; Humans | 2022 |
How Important it is to Differentiate AMAN from AIDP in Childhood GBS? A Clinician's Perspective.
Topics: Amantadine; Child; Guillain-Barre Syndrome; Humans; India; Prospective Studies | 2019 |
Interventions for fatigue in peripheral neuropathy.
Topics: Adult; Amantadine; Ascorbic Acid; Charcot-Marie-Tooth Disease; Child; Fatigue; Guillain-Barre Syndro | 2014 |
1 trial available for amantadine and Acute Autoimmune Neuropathy
| Article | Year |
|---|---|
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Anxiety; Cross-Over Studies; Depressio | 2006 |
5 other studies available for amantadine and Acute Autoimmune Neuropathy
| Article | Year |
|---|---|
Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course.
Topics: Amantadine; Guillain-Barre Syndrome; Hospital Mortality; Humans; Immunoglobulins, Intravenous; Respi | 2022 |
Reversible conduction failure in acute inflammatory demyelinating polyneuropathy.
Topics: Amantadine; Gangliosides; Guillain-Barre Syndrome; Heart Rate; Humans; Neural Conduction | 2022 |
Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves.
Topics: Amantadine; Guillain-Barre Syndrome; Humans; Neural Conduction; Retrospective Studies | 2023 |
Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves.
Topics: Amantadine; Guillain-Barre Syndrome; Humans; Neural Conduction; Retrospective Studies | 2023 |
Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves.
Topics: Amantadine; Guillain-Barre Syndrome; Humans; Neural Conduction; Retrospective Studies | 2023 |
Identical late motor responses in early Guillain-Barré syndrome: A-waves and repeater F-waves.
Topics: Amantadine; Guillain-Barre Syndrome; Humans; Neural Conduction; Retrospective Studies | 2023 |
Association between hyperCKemia and axonal degeneration in Guillain-Barré syndrome.
Topics: Amantadine; Axons; Guillain-Barre Syndrome; Hospitalization; Humans; Nerve Conduction Studies; Retro | 2023 |
Clinical and Electrophysiological Factors Predicting Prolonged Recovery in Children with Guillain-Barré Syndrome.
Topics: Amantadine; Child; Guillain-Barre Syndrome; Humans; Neural Conduction; Neurologic Examination; Progn | 2022 |